- Home
- OABI vs NPV Comparison
OABI vs NPV Comparison
Compare OABI & NPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- NPV
- Stock Information
- Founded
- OABI 2012
- NPV 1993
- Country
- OABI United States
- NPV United States
- Employees
- OABI N/A
- NPV N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- NPV Investment Managers
- Sector
- OABI Health Care
- NPV Finance
- Exchange
- OABI Nasdaq
- NPV Nasdaq
- Market Cap
- OABI 239.0M
- NPV 211.4M
- IPO Year
- OABI N/A
- NPV N/A
- Fundamental
- Price
- OABI $1.58
- NPV $11.45
- Analyst Decision
- OABI Strong Buy
- NPV
- Analyst Count
- OABI 3
- NPV 0
- Target Price
- OABI $6.67
- NPV N/A
- AVG Volume (30 Days)
- OABI 544.6K
- NPV 38.9K
- Earning Date
- OABI 11-04-2025
- NPV 01-01-0001
- Dividend Yield
- OABI N/A
- NPV 3.90%
- EPS Growth
- OABI N/A
- NPV N/A
- EPS
- OABI N/A
- NPV N/A
- Revenue
- OABI $21,094,000.00
- NPV N/A
- Revenue This Year
- OABI N/A
- NPV N/A
- Revenue Next Year
- OABI $48.89
- NPV N/A
- P/E Ratio
- OABI N/A
- NPV N/A
- Revenue Growth
- OABI 3.36
- NPV N/A
- 52 Week Low
- OABI $1.22
- NPV $8.92
- 52 Week High
- OABI $4.61
- NPV $11.55
- Technical
- Relative Strength Index (RSI)
- OABI 49.87
- NPV 53.28
- Support Level
- OABI $1.33
- NPV $11.32
- Resistance Level
- OABI $1.64
- NPV $11.58
- Average True Range (ATR)
- OABI 0.09
- NPV 0.11
- MACD
- OABI 0.01
- NPV -0.00
- Stochastic Oscillator
- OABI 55.92
- NPV 61.76
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.